# OGE Energy Corp.: financial statements, quarterly

OGE · NYSE · CIK 1021635 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oge.md) · [Financials](/companies/oge/financials.md) · [Filings](/companies/oge/filings.md) · [Insiders](/companies/oge/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oge/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [589](/filings/0000950170-24-092035.md) | [923](/filings/0000950170-24-120954.md) | [551 d](/filings/0001193125-26-055414.md) | [583](/filings/0000950170-25-060389.md) | [644](/filings/0000950170-25-099780.md) | [945](/filings/0001193125-25-253956.md) | [745 d](/filings/0001193125-26-055414.md) | [741](/filings/0001021635-26-000012.md) | [720](/filings/0000950170-25-099780.md) | [1,028](/filings/0001193125-25-253956.md) | [702 d](/filings/0001193125-26-055414.md) | [737](/filings/0001021635-26-000012.md) |
| Cost of revenue | $m | [182](/filings/0000950170-24-092035.md) | [334](/filings/0000950170-24-120954.md) | [196 d](/filings/0001193125-26-055414.md) | [232](/filings/0000950170-25-060389.md) | [194](/filings/0000950170-25-099780.md) | [350](/filings/0001193125-25-253956.md) | [300 d](/filings/0001193125-26-055414.md) | [324](/filings/0001021635-26-000012.md) | [261](/filings/0000950170-25-099780.md) | [389](/filings/0001193125-25-253956.md) | [286 d](/filings/0001193125-26-055414.md) | [337](/filings/0001021635-26-000012.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [35.8](/filings/0000950170-24-092035.md) | [35.6](/filings/0000950170-24-120954.md) | [39.3 d](/filings/0001193125-26-055414.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [146](/filings/0000950170-24-092035.md) | [331](/filings/0000950170-24-120954.md) | [96.2 d](/filings/0001193125-26-055414.md) | [74.0](/filings/0000950170-25-060389.md) | [176](/filings/0000950170-25-099780.md) | [313](/filings/0001193125-25-253956.md) | [182 d](/filings/0001193125-26-055414.md) | [133](/filings/0001021635-26-000012.md) | [187](/filings/0000950170-25-099780.md) | [341](/filings/0001193125-25-253956.md) | [138 d](/filings/0001193125-26-055414.md) | [113](/filings/0001021635-26-000012.md) |
| Interest expense | $m | [57.7](/filings/0000950170-24-092035.md) | [57.4](/filings/0000950170-24-120954.md) | [58.5 d](/filings/0001193125-26-055414.md) | [60.2](/filings/0000950170-25-060389.md) | [64.9](/filings/0000950170-25-099780.md) | [64.2](/filings/0001193125-25-253956.md) | [65.2 d](/filings/0001193125-26-055414.md) | [67.3](/filings/0001021635-26-000012.md) | [72.2](/filings/0000950170-25-099780.md) | [69.6](/filings/0001193125-25-253956.md) | [61.2 d](/filings/0001193125-26-055414.md) | [59.9](/filings/0001021635-26-000012.md) |
| Income tax | $m | [14.8](/filings/0000950170-24-092035.md) | [38.4](/filings/0000950170-24-120954.md) | [(3.8) d](/filings/0001193125-26-055414.md) | [1.6](/filings/0000950170-25-060389.md) | [19.2](/filings/0000950170-25-099780.md) | [41.0](/filings/0001193125-25-253956.md) | [17.3 d](/filings/0001193125-26-055414.md) | [10.2](/filings/0001021635-26-000012.md) | [22.0](/filings/0000950170-25-099780.md) | [45.5](/filings/0001193125-25-253956.md) | [12.1 d](/filings/0001193125-26-055414.md) | [9.2](/filings/0001021635-26-000012.md) |
| Net income | $m | [88.4](/filings/0000950170-24-092035.md) | [242](/filings/0000950170-24-120954.md) | [48.2 d](/filings/0001193125-26-055414.md) | [18.6](/filings/0000950170-25-060389.md) | [102](/filings/0000950170-25-099780.md) | [219](/filings/0001193125-25-253956.md) | [102 d](/filings/0001193125-26-055414.md) | [62.7](/filings/0001021635-26-000012.md) | [108](/filings/0000950170-25-099780.md) | [231](/filings/0001193125-25-253956.md) | [69.2 d](/filings/0001193125-26-055414.md) | [50.2](/filings/0001021635-26-000012.md) |
| Diluted EPS | $ per share | [0.44](/filings/0000950170-24-092035.md) | [1.20](/filings/0000950170-24-120954.md) | not reported | [0.09](/filings/0000950170-25-060389.md) | [0.51](/filings/0000950170-25-099780.md) | [1.09](/filings/0001193125-25-253956.md) | not reported | [0.31](/filings/0001021635-26-000012.md) | [0.53](/filings/0000950170-25-099780.md) | [1.14](/filings/0001193125-25-253956.md) | not reported | [0.24](/filings/0001021635-26-000012.md) |
| Basic EPS | $ per share | [0.44](/filings/0000950170-24-092035.md) | [1.21](/filings/0000950170-24-120954.md) | not reported | [0.09](/filings/0000950170-25-060389.md) | [0.51](/filings/0000950170-25-099780.md) | [1.09](/filings/0001193125-25-253956.md) | not reported | [0.31](/filings/0001021635-26-000012.md) | [0.53](/filings/0000950170-25-099780.md) | [1.15](/filings/0001193125-25-253956.md) | not reported | [0.24](/filings/0001021635-26-000012.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000950170-23-039989.md) | [0.0](/filings/0000950170-23-057629.md) | [0.0](/filings/0000950170-25-022560.md) | [0.0](/filings/0000950170-24-050701.md) | [0.0](/filings/0000950170-24-092035.md) | [0.0](/filings/0000950170-24-120954.md) | [0.0](/filings/0001193125-26-055414.md) | [0.0](/filings/0000950170-25-060389.md) | [0.0](/filings/0000950170-25-099780.md) | [0.0](/filings/0001193125-25-253956.md) | [0.0](/filings/0001021635-26-000012.md) | [0.0](/filings/0001021635-26-000012.md) |
| Current assets | $bn | [1.0](/filings/0000950170-23-039989.md) | [0.9](/filings/0000950170-23-057629.md) | [0.8](/filings/0000950170-25-022560.md) | [0.7](/filings/0000950170-24-050701.md) | [0.8](/filings/0000950170-24-092035.md) | [0.9](/filings/0000950170-24-120954.md) | [0.9](/filings/0001193125-26-055414.md) | [1.0](/filings/0000950170-25-060389.md) | [1.0](/filings/0000950170-25-099780.md) | [1.0](/filings/0001193125-25-253956.md) | [0.9](/filings/0001021635-26-000012.md) | [0.8](/filings/0001021635-26-000012.md) |
| Total assets | $bn | [12.6](/filings/0000950170-24-092035.md) | [12.7](/filings/0000950170-24-120954.md) | [12.8](/filings/0001193125-26-055414.md) | [12.9](/filings/0000950170-25-060389.md) | [13.2](/filings/0000950170-25-099780.md) | [13.5](/filings/0001193125-25-253956.md) | [13.7](/filings/0001193125-26-055414.md) | [14.0](/filings/0001021635-26-000012.md) | [14.1](/filings/0000950170-25-099780.md) | [14.3](/filings/0001193125-25-253956.md) | [14.4](/filings/0001021635-26-000012.md) | [14.5](/filings/0001021635-26-000012.md) |
| Current liabilities | $bn | [1.1](/filings/0000950170-23-039989.md) | [1.1](/filings/0000950170-23-057629.md) | [1.2](/filings/0000950170-25-022560.md) | [1.4](/filings/0000950170-24-050701.md) | [1.1](/filings/0000950170-24-092035.md) | [1.0](/filings/0000950170-24-120954.md) | [1.2](/filings/0001193125-26-055414.md) | [1.4](/filings/0000950170-25-060389.md) | [1.3](/filings/0000950170-25-099780.md) | [1.2](/filings/0001193125-25-253956.md) | [1.1](/filings/0001021635-26-000012.md) | [1.2](/filings/0001021635-26-000012.md) |
| Total liabilities | $bn | [8.2](/filings/0000950170-23-039989.md) | [8.2](/filings/0000950170-23-057629.md) | [8.3](/filings/0000950170-25-022560.md) | [8.5](/filings/0000950170-24-050701.md) | [8.7](/filings/0000950170-24-092035.md) | [8.9](/filings/0000950170-24-120954.md) | [9.1](/filings/0001193125-26-055414.md) | [9.3](/filings/0000950170-25-060389.md) | [9.4](/filings/0000950170-25-099780.md) | [9.5](/filings/0001193125-25-253956.md) | [9.4](/filings/0001021635-26-000012.md) | [9.5](/filings/0001021635-26-000012.md) |
| Long-term debt | $bn | [4.3](/filings/0000950170-23-039989.md) | [4.3](/filings/0000950170-23-057629.md) | [4.3](/filings/0000950170-25-022560.md) | [4.3](/filings/0000950170-24-050701.md) | [4.8](/filings/0000950170-24-092035.md) | [5.0](/filings/0000950170-24-120954.md) | [5.0](/filings/0001193125-26-055414.md) | [5.1](/filings/0000950170-25-060389.md) | [5.4](/filings/0000950170-25-099780.md) | [5.4](/filings/0001193125-25-253956.md) | [5.4](/filings/0001021635-26-000012.md) | [5.4](/filings/0001021635-26-000012.md) |
| Current portion of debt | $bn | [0.0](/filings/0000950170-23-039989.md) | [0.0](/filings/0000950170-23-057629.md) | [0.0](/filings/0000950170-25-022560.md) | [0.1](/filings/0000950170-24-050701.md) | [0.1](/filings/0000950170-24-092035.md) | [0.0](/filings/0000950170-24-120954.md) | [0.0](/filings/0001193125-26-055414.md) | [0.0](/filings/0000950170-25-060389.md) | [0.0](/filings/0000950170-25-099780.md) | [0.0](/filings/0001193125-25-253956.md) | [0.0](/filings/0001193125-26-055414.md) | not reported |
| Short-term borrowings | $bn | [0.4](/filings/0000950170-23-039989.md) | [0.4](/filings/0000950170-23-057629.md) | [0.5](/filings/0000950170-25-022560.md) | [0.8](/filings/0000950170-24-050701.md) | [0.4](/filings/0000950170-24-092035.md) | [0.2](/filings/0000950170-24-120954.md) | [0.5](/filings/0001193125-26-055414.md) | [0.8](/filings/0000950170-25-060389.md) | [0.5](/filings/0000950170-25-099780.md) | [0.5](/filings/0001193125-25-253956.md) | [0.3](/filings/0001021635-26-000012.md) | [0.5](/filings/0001021635-26-000012.md) |
| Shareholders' equity | $bn | [4.4](/filings/0000950170-23-039989.md) | [4.5](/filings/0000950170-23-057629.md) | [4.5](/filings/0000950170-25-022560.md) | [4.4](/filings/0000950170-24-050701.md) | [4.5](/filings/0000950170-24-092035.md) | [4.6](/filings/0000950170-24-120954.md) | [4.6](/filings/0001193125-26-055414.md) | [4.6](/filings/0000950170-25-060389.md) | [4.6](/filings/0000950170-25-099780.md) | [4.8](/filings/0001193125-25-253956.md) | [5.0](/filings/0001021635-26-000012.md) | [4.9](/filings/0001021635-26-000012.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [334 d](/filings/0000950170-24-092035.md) | [415 d](/filings/0000950170-24-120954.md) | [311 d](/filings/0001193125-26-055414.md) | [83.0](/filings/0000950170-25-060389.md) | [253 d](/filings/0000950170-25-099780.md) | [347 d](/filings/0001193125-25-253956.md) | [130 d](/filings/0001193125-26-055414.md) | [15.9](/filings/0001021635-26-000012.md) | [339 d](/filings/0000950170-25-099780.md) | [398 d](/filings/0001193125-25-253956.md) | [385 d](/filings/0001193125-26-055414.md) | [176](/filings/0001021635-26-000012.md) |
| Capital expenditure | $m | [295 d](/filings/0000950170-24-092035.md) | [299 d](/filings/0000950170-24-120954.md) | [299 d](/filings/0001193125-26-055414.md) | [227](/filings/0000950170-25-060389.md) | [323](/filings/0000950170-25-099780.md) | [244](/filings/0001193125-25-253956.md) | [297 d](/filings/0001193125-26-055414.md) | [250](/filings/0001021635-26-000012.md) | [274](/filings/0000950170-25-099780.md) | [230](/filings/0001193125-25-253956.md) | [302 d](/filings/0001193125-26-055414.md) | [267](/filings/0001021635-26-000012.md) |
| Dividends paid | $m | [82.9 d](/filings/0000950170-24-092035.md) | [82.9 d](/filings/0000950170-24-120954.md) | [83.8 d](/filings/0001193125-26-055414.md) | [85.9](/filings/0000950170-25-060389.md) | [84.0 d](/filings/0000950170-25-099780.md) | [84.0 d](/filings/0001193125-25-253956.md) | [84.6 d](/filings/0001193125-26-055414.md) | [86.6](/filings/0001021635-26-000012.md) | [84.9 d](/filings/0000950170-25-099780.md) | [84.8 d](/filings/0001193125-25-253956.md) | [85.6 d](/filings/0001193125-26-055414.md) | [89.1](/filings/0001021635-26-000012.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [201](/filings/0000950170-23-039989.md) | [201](/filings/0000950170-23-057629.md) | [201](/filings/0000950170-24-050701.md) | [201](/filings/0000950170-24-092035.md) | [201](/filings/0000950170-24-120954.md) | [201](/filings/0000950170-25-060389.md) | [201](/filings/0000950170-25-099780.md) | [202](/filings/0001193125-25-253956.md) | [202](/filings/0001021635-26-000012.md) | [202](/filings/0000950170-25-099780.md) | [202](/filings/0001193125-25-253956.md) | [207](/filings/0001021635-26-000012.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 206,374,321 at 2026-03-31, from the cover of the [10-Q filed 2026-04-29](/filings/0001021635-26-000012.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.